Conviction from: NASDAQ
Enliven Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule kinase inhibitors aimed at treating cancer.
Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.
from2028 — cross-site stock view. Rebuilt at publish time.